Table 1 Distribution of the study variables in kidney transplant and liver transplant recipients with Acinetobacter baumannii infection
Variable | Liver transplant (total = 25) | Kidney transplant (total = 24) | p |
|---|---|---|---|
n (%) | n(%) | ||
Male sex | 16 (64) | 13 (54) | 0.48 |
Agea | 56 (38–63) | 44 (31–55) | 0.09 |
Infection acquired in the ICU | 22 (88) | 2 (8) | <0.001 |
Previous use of any antibioticb | 11 (55) | 11 (55) | 1.0 |
Previous use of carbapenem b | 8 (40) | 3 (15) | 0.08 |
Non-urinary site of infection | 24 (96) | 11 (46) | <0.001 |
Primary bacteremia | 9 (36) | 8 (33) | |
Pneumonia | 11 (44) | 2 (18) | |
Surgical site infection | 4 (16) | 1 (4) | |
Bacteremia c | 16 (64) | 12 (50) | 0.32 |
Central venous catheter | 25 (100) | 6 (25) | <0.001 |
Mechanical ventilation | 21 (84) | 4 (17) | <0.001 |
Serum creatinine (μmol/L ) a | 130 (90 – 200) | 320 (120–500) | 0.009 |
Hemodialysis | 8 (32) | 4 (17) | 0.21 |
Treated for acute graft rejection | 1 (4) | 11 (46) | 0.001 |
Septic shock | 11 (44) | 4 (17) | 0.04 |
Appropriate empiric therapy for A. baumannii infection | 17 (68) | 12 (50) | 0.20 |
Resistance to carbapenem | 12 (48) | 6 (33) | 0.10 |